<DOC>
	<DOCNO>NCT00423683</DOCNO>
	<brief_summary>The development clot potentially deadly complication many cancer patient . The current optimal treatment unknown . Evidence support effectiveness use Inferior Vena Caval Filters lack . This study compare two standard care treatment option : anticoagulation without inferior vena cava filter . The anticoagulation medication choose Arixtra give day injection . Patients call various interval monitor sign symptom new thromboembolism .</brief_summary>
	<brief_title>Anticoagulation Inferior Vena Cava Filters Cancer Patients With Venous Thromboembolism</brief_title>
	<detailed_description>The development clot potentially deadly complication many cancer patient . The current optimal treatment unknown . Evidence support effectiveness use Inferior Vena Caval Filters lack . This study compare two standard care treatment option : anticoagulation without inferior vena cava filter . The anticoagulation medication choose Arixtra give day injection . Patients call various interval monitor sign symptom new thromboembolism . Patients equally randomize receive either Arixtra without placement Inferior Vena Cava ( IVC ) filter . Fifty three patient expect enrolled arm . Patients monitor 90 day study enrollment . Monitoring include telephone call physician visit repeat radiologists patient symptomatic Deep Vein thrombosis ( DVT ) . This also include completion quality life questionnaire .</detailed_description>
	<mesh_term>Thromboembolism</mesh_term>
	<mesh_term>Venous Thromboembolism</mesh_term>
	<mesh_term>Fondaparinux</mesh_term>
	<mesh_term>PENTA</mesh_term>
	<criteria>Documentation cancer . The disease may solid tumor , Lymphoma Multiple Myeloma . Pathology report document patient 's chart include data . Age &gt; 18 year An acute , radiographically confirm , de novo Deep Vein Thrombosis ( DVT ) Pulmonary Embolism ( PE ) No past medical history prior thrombus know thrombophilia Exclusion Criteria Patients eligible study receive therapeutic dos heparin 72 hour randomization 31 . Already receive oral anticoagulant therapy 31 . Severe renal impairment , calculate use CockcroftGault formula , define creatinine clearance &lt; 30 mL/min 31 . Platelet count le 50,000 per cubic millimeter Bleeding gastrointestinal tract require blood transfusion ( ) , intracranial bleeding retroperitoneal bleeding . An indication thrombolysis Allergy iodine Hereditary thrombophilia Pregnancy Likelihood noncompliance It contraindicate anticoagulate patient brain metastasis secondary melanoma , choriocarcinoma , renal cell medullary thyroid carcinoma . If patient Venous Thromboembolism ( VTE ) , standard care patient CT head evaluate metastasis brain anticoagulated 38 . If patient brain metastasis , include study .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>May 2016</verification_date>
	<keyword>Cancer</keyword>
	<keyword>thromboembolism</keyword>
</DOC>